Publications
Annual Biomed is raising the goal
MiXiii-Biomed opened its doors this morning and brings the latest news and events in the field of Biomedicine to the attention of the participants. A
MIXiii-Biomed 2019: Grand Opening Tomorrow
We welcome you to The 18th National LIfe Science & Technology Week PROGRAM REGISTRATION TO READ THE LATEST NEWS IN THE BIOMEDICAL FIELD, JOIN OUR
MIXiii-BIOMED 2019: Kind Reminder – (only) 1 day left
Last day left to take advantage of the Early Bird Registration We want to make sure you receive the best value for your money.
MIXiii-BIOMED 2019: Register Now – Only 2 (two) days left..
Only 2 (two) days left to take advantage of the Early Bird Registration Make sure you are part of this prestigious MIXiii-Biomed 2019 Event and
MIXiii-BIOMED 2019 – EARLY BIRD REGISTRATION ADVANTAGE
Make sure you are part of this prestigious MIXiii-Biomed 2019 Event and save on the registration fee by registering no later than Wednesday, May
MIXiii-Biomed 2019: Preliminary Program
Scientific Program online – Register Now MIXiii-Biomed 2019 is fast approaching. The high standard scientific program is ready to deliver a wealth of information, new
BIOMED Event In The Press
See MIXIII Biomed in the news around the world.
To save the most precious – Life! (Russian)
Novosty Nedely – An article by Yakov Zobrayev that visited the convention. Translation into Hebrew: מובאים בכתבה רשמיו של הכותב יעקב זוברייב מהכנס Mixiii-BioMed שהתקיים
30 Israeli companies bring medtech innovations to North of England
30 Israeli companies bring medtech innovations to North of England 29 May 2019 RSS More than 30 Israeli companies have accessed support to help
The biomed market is flourishing, so how can the generics companies stay out of the party?
שוק הביומד פורח, אז איך יכול להיות שחברות הגנריקה נשארו מחוץ לחגיגה מהפכת הגנום הובילה לפיתוח ואישור תרופות בקצב מהיר בעבר, מהפכת המידע דוחפת את
‘Greatest emerging market’? Cannabis-based drug R&D finally going mainstream
By Alfred Romann, Staff Writer | Wednesday, May 22, 2019 | BioWorld TEL AVIV, Israel – An awakening is underway in the biotech field to develop new
The bio-tech industry has been identified as an economic growth in Israel
THE JERUSALEM INSTITUTE HAS PREPARED FOR THE JERUSALEM DEVELOPMENT AUTHORITY A REPORT PRESENTING STATISTICAL DATA ON THE LIFE SCIENCES INDUSTRY IN JERUSALEM Published: 13.5.19 |
Not only Eurovision: The global biomed industry is also meeting in Tel Aviv
And also: Hillel Yaffe Medical Center in Hadera is looking for a different experience לא רק אירוויזיון: גם תעשיית הביומד העולמית מתכנסת בתל אביב וגם: המרכז
Latest Publications in the field
Find out the latest publications, innovations and news in the field of ophthalmology. To receive the latest news in the field, join our Linkedin group.
Immunotherapy that promotes organ transplant acceptance
NOVEMBER 07, 2018 | RESEARCH Researchers have developed a novel type of immunotherapy based on innovative nanotechnology that induces long-term organ transplant acceptance in mice. Their study,
Researchers fight Alzheimer’s disease using nanoparticles
OCTOBER 10, 2018 | RESEARCH About 29 million people around the world are affected by the disease “Alzheimer”. In an international collaboration, scientists of the Max Planck
Nanoparticle therapy restores prostate cancer’s tumor suppressor
Research | SEPTEMBER 18, 2018 Using nanotechnology, researchers have developed a way to treat prostate cancer by restoring tumor suppressors, based on preclinical models in the lab. The
Israeli researchers say new treatment could boost fertility in women and men
#MedicalScientists say single dose of compound developed at #Ben-GurionUniversity could speed up #eggmaturation and #ovulation By SHOSHANNA SOLOMON #Israeliresearchers say they may have found a new
Eye implants for glaucoma patients inspired by Butterfly wings
May 01, 2018 – RESEARCH Inspired by tiny structures on transparent #butterflywings, scientists have developed a light-#manipulatingsurface for more effective and longer-lasting #eyeimplants for
Israeli cancer profiling co NovellusDx raises $6m
NovellusDx CEO: The funds will let us move into commercialization and enable us to meet the need for functional oncology worldwide. #Israeli #functionalgenomics and